Home Programme About Performers Venue Registration Contact

Monday 3rd June 2013, Noon

„Single-use technology in biopharmaceutical manufacturing: Tomorrow“

Vaccines and cell therapeutics

Session Chair:
Regine Eibl, Zurich University of Applied Sciences, Switzerland

New developments and trends in upstreaming, downstreaming, formulation and filling

Session Chair:
Detlef Eisenkrätzer, Roche Diagnostics GmbH, Germany 


13:00- 13:30

Viral vaccine development and production: current state and trends

13:00- 13:25

New Levitronix single-use pump series PuraLev®: characteristics and investigations of mechanical stress


Alain Prolang,
GlaxoSmithKline, Belgium


Stephan C. Kaiser, Zurich University of Applied Sciences, Switzerland and Wolfgang Dornfeld, Levitronix GmbH, Switzerland

13:30- 14:00

Practical applications of single use technology for the production of recombinant VLP and nanoparticle vaccines

13:25- 15:50

Improved Bioreactor Design for Laboratory to Production Suite Operations


Timothy Hahn,
Novavax Inc., USA


Henry Charlton, Pall Corporation

14:00- 14:30

Development of a single-use system based production platform for stem cell expansion

13:50- 14:15

Eppendorf’s single-use solutions: rigid-wall bioreactors from 100mL- up to 50L


Christian van den Bos,
Lonza Cologne AG, Germany


Christof Knocke, Vaudaux Eppendorf AG, Switzerland

14:30- 15:00

hMSC production in disposable bioreactors with regards to GMP and PAT

14:15- 14:40

Linear scalability for viral entities production in iCELLis™ disposable fixed-bed bioreactor from bench-scale to industrial scale


Peter Czermak,
Technische Hochschule Mittelhessen and Kansas State University, Germany/USA


Mathieu Cesari, ATMI LifeSciences, Belgium


Next generation downstream template for continuous mAb processing

      Sébastien Ribault, Merck Millipore, France
Coffee break and exhibition (Building GA)


Zum Hauptmenu
Zum Untermenu
Zum Inhalt